Theme - Trust, Transparency & Technology: Navigating Complexity in the Era of Augmented Pharmacovigilance

Session 1: Target, lead identification and lead selection, In vitro pharmacology, (AI in discovery) - 08th August 2026

Session 2: DMPK (PBPK modeling) - 22nd August 2026

Session 3: Toxicology - 29th August 2026

Session 4: Regulatory, Early clinical Development - 05th September 2026

Session 5: Translation overview and Case studies - 19th September 2026

-

-

-

-

-

Introduction: The ISCR Medical Writing Symposium 2026 aims to equip medical writing professionals with the strategic, scientific, and regulatory skills needed in an era of AI-augmented drug development. Through expert-led sessions and panel discussions, the symposium will explore evolving expectations in regulatory writing, publication strategy, AI integration, and real-world evidence communication. The programme provides a platform for knowledge exchange, cross-functional collaboration, and alignment with global standards, to enhance the quality, clarity, and impact of scientific communication across the drug development continuum.

.